Publications: Nina A. Hering
home page home page|
PubMed list of Nina Hering, |
2025
Masete KV, Günzel D, Schulzke JD, Epple HJ*, Hering NA* (*shared last authorship) (2025) Matrix-free human 2D organoids recapitulate duodenal barrier and transport properties. BMC Biol. 23(1): 2 (13 pages). doi: 10.1186/s12915-024-02105-7 (°IF 4.4)
2024
###
2023
Hader H, Hering NA, Schulzke JD, Bücker R, Rosenthal R (2023) Myrrh protects against IL-13-induced epithelial barrier breakdown in HT-29/B6 cells. Front. Pharmacol. 14: 1301800 (11 pages). doi: 10.3389/fphar.2023.1301800 (IF 4.4)
2021
Hering NA, Luettig J, Jebautzke B, Schulzke JD, Rosenthal R (2021) The punicalagin metabolites ellagic acid and urolithin A exert different strengthening and anti-inflammatory effects on tight junction-mediated intestinal barrier function in vitro. Front. Phamacol. 12: 610164, doi: 10.3389/fphar.2021.610164 (IF 6.0)
2019
Hering NA, Fromm A, Bücker R, Gorkiewicz G, Zechner EL, Högenauer C, Fromm M, Schulzke JD, Troeger H (2019) Tilivalline- and tilimycin-independent effects of Klebsiella oxytoca on tight junction-mediated intestinal barrier impairment. Int. J. Mol. Sci. 20(22): 5595 (16 pages) (IF 4.6) [PubMed] [WebPage] [PDF]
Subramaniam S, Müller VS, Hering NA, Mollenkopf H, Becker D, Heroven AK, Dersch P, Pohlmann A, Tedin K, Porwollik S, McClelland M, Meyer TF, Hunke S. (2019) Contribution of the Cpx envelope stress system to metabolism and virulence regulation in Salmonella enterica serovar Typhimurium. PLoS One 14(2): e0211584, Erratum in 14(2): e0213297 (IF 2.7) [PubMed] [WebPage] [PDF]
2018
Bücker R, Krug SM, Moos V, Bojarski C, Schweiger MR, Kerick M, Fromm A, Janßen S, Fromm M, Hering NA, Siegmund B, Schneider T, Barmeyer C, Schulzke JD (2018) Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon. Mucosal Immunol. 11(2): 474-485 (IF 7.4) [PubMed] [DOI] [PDF] [Supplement1] [Supplement2]
Troeger H, Hering NA, Bojarski C, Fromm A, Barmeyer C, Uharek L, Siegmund B, Fromm M, Rieger K*, Schulzke JD* (*shared last authorship) (2018) Epithelial barrier dysfunction as permissive pathomechanism in human intestinal graft-versus-host disease. Bone Marrow Transplant.
2017
Hering NA, Luettig J, Krug SM, Wiegand S, Gross G, van Tol EA, Schulzke JD*, Rosenthal R* (*shared last authorship) (2017) Lactoferrin protects against intestinal inflammation or bacteria-induced barrier dysfunction in vitro. Ann. N.Y. Acad. Sci. 1405: 177-188 (IF 4.3) [PubMed] [WebPage] [PDF]
2016
Hering NA, Fromm A, Kikhney J, Lee IM, Moter A, Schulzke JD, Bücker R (2016) Yersinia enterocolitica affects intestinal barrier function in the colon. J. Infect. Dis. 213(7): 1157-1162 (IF 6.3) [PubMed] [WebPage] [PDF]
Rosenthal R, Luettig J, Hering NA, Krug SM, Albrecht U, Fromm M, Schulzke JD (2017) Myrrh exerts barrier-stabilizing and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells. Int. J. Colorectal Dis. 32(5): 623-634 (IF 2.4) [PubMed] [WebPage] [PDF]
2014
Hering NA*, Richter JF* (*shared first authorship), Fromm A, Wieser A, Hartmann S, Günzel D, Bücker R, Fromm M, Schulzke JD° (°corresponding author), Troeger H (2014) TcpC protein from E. coli Nissle improves epithelial barrier function involving PKCζ and ERK1/2 signalling in HT-29/B6 cells. Mucosal Immunol. 7(2): 369-378 (IF 7.4) [PubMed] [WebPage] [PDF]
Whelan RA*, Rausch S* (*shared first authorship), Ebner F, Günzel D, Richter JF, Hering NA, Schulzke JD, Kühl AA, Keles A, Janczyk P, Nöckler K, Wieler LH, Hartmann S (2014) A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation. Mol. Ther. 22(10): 1730-1740 (IF 6.2) [PubMed] [WebPage] [PDF]
2012
Review
Hering NA, Fromm M, Schulzke JD (2012) Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics. J. Physiol. 590(5): 1035-1044 (IF 4.4) [PubMed] [WebPage] [PDF]
2011
Hering NA*, Andres S* (*shared first authorship), Fromm A, van Tol EA, Amasheh M, Mankertz J, Fromm M, Schulzke JD (2011) Transforming growth factor b, a whey protein component, strengthens the intestinal barrier by upregulating claudin-4 in HT-29/B6 cells. J. Nutr. 141(5): 783-789 (IF 3.9) [PubMed] [WebPage] [PDF]
Hering NA, Richter JF, Krug SM, Günzel D, Fromm A, Bohn E, Rosenthal R, Bücker R, Fromm M, Troeger H, Schulzke JD (2011) Yersinia enterocolitica induces epithelial barrier dysfunction through regional tight junction changes in colonic HT-29/B6 cell monolayers. Lab. Invest. 91(2): 310-324 (IF 3.6) [PubMed] [WebPage] [PDF] [Supplement DOC]
Nielsen HL, Nielsen H, Ejlertsen T, Engberg J, Günzel D, Zeitz M, Hering NA, Fromm M, Schulzke JD, Bücker R (2011) Oral and fecal Campylobacter concisus strains perturb barrier function by apoptosis induction in HT-29/B6 intestinal epithelial cells. Plos
2009
Review
Hering NA, Schulzke JD (2009) Therapeutic options to modulate barrier defects in inflammatory bowel disease. Dig. Dis. 27(4): 450-454 (IF 1.5) [PubMed]
Diploma Thesis
Hering NA (2010) Die epitheliale Barriere als Zielstruktur pathogener und probiotischer Bakterien: Wirkmechanismen von Y. enterocolitica und
E. coli Nissle.
Dissertation, Biologie, FU Berlin,
14.12.10 Dr. rer. nat., Magna cum laude
Hering NA (geb. Otto) (2005) Untersuchung der Rolle des Cpx-Sensor-Regulatorsystems für die Pathogenität von Salmonella typhimurium. Diploma thesis [Biology, Humboldt University Berlin, supervision Schneider E (Faculty of Mathematics and Natural Sciences I, Institute of Biology)]